MedTrace Logo

Combination of Glinides With Premixed Insulin

NCT00369148 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-08-26

No results posted yet for this study

Summary

Combination therapy of glinides with premixed insulin provides better glycemic control than premixed insulin alone.

Conditions

  • Type 2 Diabets Mellitus

Interventions

DRUG

nateglinide(drug) mitiglinide(drug)

Sponsors & Collaborators

  • Keio University

    lead OTHER

Principal Investigators

  • Akira Shimada, MD, PhD · Keio University

  • Yoshihito Atsumi, MD · Saiseikai Central Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2006-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00369148 on ClinicalTrials.gov